Medilink Midlands News & Opportunities
Medilink Midlands
Transforming the Healthcare Industry by connecting Academics, Businesses and the NHS
The latest edition of our newsletter covers a host of good news and opportunities from across our community.
News
A leading UK contract development and manufacturing organisation Upperton Pharma Solutions , has completed the build of its new sterile manufacturing facility in Nottingham.
IMed Consultancy Ltd ’s new free whitepaper, “PMS from pain to potential: more than just ticking a box”, reveals how to transform gruelling PMS procedures into commercial benefit.
Coauthor by Hindsight explores the concept of predictive compliance in medical device manufacturing and how tools are pioneering this new approach in its latest blog.
Medilink Midlands will be offering a limited number of discounted exhibition stands for our members, and running the popular one-to-one Discovery Talks with international representatives.
领英推荐
The Computing and Advanced Microscopy Development Unit at Warwick Medical School houses cutting-edge imaging systems and powerful analytical resources that are driving innovation in biomedical and medical science.
The Medilink Midlands Innovation Builder is designed to best serve the exact needs of innovators from across academia and industry. Making sure you have the right tools to put you on the right pathway?to commercialisation and investment sources. First round applications close on 28 February.
Opportunities
The UKRI Proof of Concept funding opportunity aims to support and accelerate the development of new or improved technologies, products, processes, and services arising from research activities at eligible UK research organisations.
If you're a Leicester based innovator?looking to meet with innovation experts offering tangible advice on product development, funding advice, regulation - all the way through to engaging with the NHS, sign up to the next clinic - taking place on?11 March.
Nottingham Trent University ran an online event to gather user requirements (particularly focused on marketisation and stakeholder engagement) for Phase-IV-AI, an EU funded project developing a “Health Data Hub”, which provides access to the project’s data synthetisation services (DaaS) and multi-party computation services (MaaS).